Arkolith/Insider Trading/SYN/Form 4

Shallcross Steven A

CEO and CFO, DirectorSynthetic Biologics, Inc. (SYN) · full profile →Form 4 · filed May 10, 2021
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 10, 2021Buy(P)50K$0.49$25K100K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-064047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML